Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1370374
PUBLISHER: IMARC | PRODUCT CODE: 1370374
Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
Market Overview:
The global hospital infection therapeutics market size reached US$ 11.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028.
Hospital infection therapeutics refers to various pharmaceutical drugs used for the treatment of nosocomial infections. These infections can be acquired at hospitals, nursing homes, rehabilitation facilities and other clinical settings and are usually treated by antiviral, antibacterial and antifungal medicines. The antibacterial therapeutics consist of cell wall synthesis and protein synthesis inhibitors, such as vancomycin, carbapenems, cephalosporins, linezolid, aminoglycosides and tigecycline. The antifungal therapeutics include caspofungin and Amphotericin B. These drugs aid in preventing the instances of hospital-acquired pneumonia, urinary tract infections (UTIs), gastrointestinal disorders, bloodstream infections and surgical site infections.
The increasing prevalence of hospital-acquired diseases (HAD) is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Resulting from the deterioration of hygiene facilities in hospitals and other healthcare institutions, there has been a significant increase in the occurrence of hospital-acquired pneumonia and other infections, which is contributing to the increasing demand for hospital infection therapeutics. Additionally, various product innovations, such as the development of advanced microbial wound care drugs, coverings and vaccines, are acting as other growth-inducing factors. Product manufacturers are developing antimicrobial drugs and pipeline drug molecules that are effective against multi-drug resistant infections and can be used for the treatment of infections with specific symptoms. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are expected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hospital infection therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug type and indication.
Breakup by Drug Type:
Anti-bacterial Drugs
Anti-fungal Drugs
Anti-viral Drugs
Others
Breakup by Indication:
Blood Stream Infections
Urinary Tract Infections
Surgical Site Infections
Pneumonia
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc (AbbVie Inc.), AstraZeneca Plc, Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG (Roche Holding AG), Gilead Sciences Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc, Pfizer Inc. and Sanofi S.A.
Key Questions Answered in This Report:
- How has the global hospital infection therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global hospital infection therapeutics market?
- What are the key regional markets?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the indication?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global hospital infection therapeutics market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A2393
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Hospital Infection Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Type
- 6.1 Anti-bacterial Drugs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Anti-fungal Drugs
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Anti-viral Drugs
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Indication
- 7.1 Blood Stream Infections
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Urinary Tract Infections
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Surgical Site Infections
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pneumonia
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Allergan Plc (AbbVie Inc.)
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 AstraZeneca Plc
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Bayer Aktiengesellschaft
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Bristol-Myers Squibb Company
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 F. Hoffmann-La Roche AG (Roche Holding AG)
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 SWOT Analysis
- 13.3.6 Gilead Sciences Inc.
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 GlaxoSmithKline Plc
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Johnson & Johnson
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Merck & Co. Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Pfizer Inc.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.11 Sanofi S.A.
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.1 Allergan Plc (AbbVie Inc.)
Product Code: SR112023A2393
List of Figures
- Figure 1: Global: Hospital Infection Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Hospital Infection Therapeutics Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Hospital Infection Therapeutics Market: Breakup by Drug Type (in %), 2022
- Figure 4: Global: Hospital Infection Therapeutics Market: Breakup by Indication (in %), 2022
- Figure 5: Global: Hospital Infection Therapeutics Market: Breakup by Region (in %), 2022
- Figure 6: Global: Hospital Infection Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 7: Global: Hospital Infection Therapeutics (Anti-bacterial Drugs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 8: Global: Hospital Infection Therapeutics (Anti-bacterial Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 9: Global: Hospital Infection Therapeutics (Anti-fungal Drugs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Hospital Infection Therapeutics (Anti-fungal Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Hospital Infection Therapeutics (Anti-viral Drugs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Hospital Infection Therapeutics (Anti-viral Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Hospital Infection Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Hospital Infection Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Hospital Infection Therapeutics (Blood Stream Infections) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Hospital Infection Therapeutics (Blood Stream Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Hospital Infection Therapeutics (Urinary Tract Infections) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Hospital Infection Therapeutics (Urinary Tract Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Hospital Infection Therapeutics (Surgical Site Infections) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Hospital Infection Therapeutics (Surgical Site Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Hospital Infection Therapeutics (Pneumonia) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Hospital Infection Therapeutics (Pneumonia) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Hospital Infection Therapeutics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Hospital Infection Therapeutics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: North America: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: North America: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: United States: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: United States: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Canada: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Canada: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Asia Pacific: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Asia Pacific: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: China: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: China: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Japan: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Japan: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: India: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: India: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: South Korea: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: South Korea: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Australia: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Australia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Indonesia: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Indonesia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Others: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: Europe: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: Europe: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Germany: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Germany: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: France: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: France: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: United Kingdom: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: United Kingdom: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Italy: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Italy: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Spain: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Spain: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Russia: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Russia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Others: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Latin America: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Latin America: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Brazil: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Brazil: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Mexico: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Mexico: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Others: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Middle East and Africa: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Middle East and Africa: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Global: Hospital Infection Therapeutics Industry: SWOT Analysis
- Figure 74: Global: Hospital Infection Therapeutics Industry: Value Chain Analysis
- Figure 75: Global: Hospital Infection Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Hospital Infection Therapeutics Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
- Table 3: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
- Table 4: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 5: Global: Hospital Infection Therapeutics Market Structure
- Table 6: Global: Hospital Infection Therapeutics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.